GlaxoSmithKline S.A.E. (BIOC.CA)

Also known as:  GSK Egypt, GlaxoSmithKline Egypt
Data delayed by 15 minutes
27.39 EGP -0.23-0.833%
As of 26 JAN 2022 12:10 GMT|Egypt SE

GSK Egypt Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
1.72%
P/E (Last 12 Month)
0.0
Upside
-
Target Price (Mean)
-
52Wk
26.93 17 JAN
33.25 02 JAN

Open
27.90 EGP
Previous Close
27.62 EGP
Turnover
784.52K EGP
EPS
-
Volume
28,709
Transactions
72
Market Cap
2.31B EGP
IPO Date
01-Sep-1993
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About GlaxoSmithKline S.A.E.

Country of Incorporation
Established In
1981
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
BIOC.CASEOrdinaryEGPEgypt SEBIOC

Contact details

Primary address
Building: Boomerang Building 46, Block J
Street: Ninety Street
Floor: 1st-3rd Floor
Area: 5th Settlement
P.O. Box: 41
Country: Egypt
City: Cairo
City Suffix: 11835
CONTACT
    Region
    Cairo
    More
    All Health Care News
    All Markets News

    Ownership

    Revenue
    Net Income
    Profit Margin
    Total Assets
    Total Liabilities
    Debt to Assets
    Operating
    Investing
    Financing

    Company information provided by Refinitiv

    Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

    Peers

    StocksLast Price% Change
    ADVANCED PHARMA1.220 EGP0.00
    MEDICAL PACK0.363 EGP-0.82
    ALX. PHARMACEUT.108.880 EGP0.712
    CLEOPATRA HOSP4.900 EGP1.871
    EGYPT INTL PHRM40.750 EGP-0.561
    ARAB PHARM51.010 EGP-2.949
    More

    Friday Outlook: Asian stocks recover; dollar set for sparkling week

    Friday Outlook: Asian stocks recover; dollar set for sparkling week

    Investors juggle positive economic news with mixed corporate earnings

    More

    Most Viewed Stocks

    Stock Screener

    More